₦airaland Forum

Op,

Next time, seek my consent before you upload my picture. Gracia

najaka:
Yes ooo! I love it

What?

praisesconsult:
Hello guys ! How's the process going? Sorry I haven't been regular here
Expecting you guys soon !

Are you in Pecs?

bsideboii:
These guys always want something unique.

"Sir" and "Rumi" or you can call them "Sarumi" awon omo Carter.

Question1:
All the best.

Thanks man

Question1:
OH, As per the Tier 4 guidance you might struggle hard to convince the VO about the genuineness of this your sponsor.

But I'm sure you're better of moving this fund into your own account to avoid stories.

Justwise over to you.

Thanks bruh.. I'm on it!

mimilyrics:
Yes, you'd have issues convincing the entry clearance officer about the sponsorship except it's an international company. I had the same issue too when my school refused to process my CAS because the CAS Team didn't go through the letter as they just assumed it was a non-international company. It took the grace of God that got me to ask them for evidence that the company didn't meet the T4 guidance, my pointing it out to them and showing them the company's international addresses and my citing the T4 guidance to get them give the letter a thorough look before they processed my CAS.

So I'd advise you as @justwise did me when the situation happened, get the cash in your account if yu can convince the company.

Thanks mimilyrics, I'll definitely do something about it

Question1:
You might need to provide a sponsorship letter issued by the sponsor.

Is it an international organization?

Oh.. Great!
I've got no problem with the sponsorship letter. Thanks so much bruh

No, not an international organization

Morning fam

I need you guys to help me on this

If a company sponsors my maintenance fees (cash in the company's account), won't I have a problem with the VO?

NOTE
*All documents are intact
*Tuition fees waived
*The cash can't be moved to my account or parent's

yemmy75:
Will i be considered automatically for the scholarship, or do i have to apply separately?

I am not so sure... But not all Commonwealth Shared Scholarship applicants got this scholarship..

yomyjoe:
No sir, I applied myself and paying my tuition fees.

Great! I just had my interview some minutes ago and it was positive. Are you in Hungary already? I just sent you a PM.. Kindly respond

[quote author=yomyjoe post=57845973]No sir, I applied myself and paying my tuition fees.
Great! I just had my interview some minutes ago and it was positive. Are you in Hungary already? I just sent you a PM.. Kindly respond

yemmy75:
Hey bro... How did you go about applying for the scholarship? Wat does it cover... I mean is it a full scholarship?

It is 75% tuition cut not full scholarship. I didn't apply for it, I only applied for the Commonwealth Shared Scholarship which I didn't get but was compensated with the Westminster scholarship.

yomyjoe:
Hi guys, thanks for the contribution...I am waiting for the skype interview from university of pecs as I applied for masters in computer science engineering, so I want to ask the questions they asked if u can still remember and how long was the interview for. Pls jus give me general tips so I can prepare well. Thank you

Cc @Jeffrey09 @praisesconsult @Amefreeka

Did you apply through Tempus scholarship?

See work experience

Over 20 years experience in Armed robbery!!

CV ti kun

Lifestone:
This disease killed Nosa, an actor on the NTA tv series, Behind the Cloud in the 80s. It's a shame that with this level of information, meningitis is still killing at epidemic level in Nigeria.
Cleanliness is key here.

Yes, You are quite right

cyzonsuez:
Hi, how far ve u gone . I sent u a message

Seen!
I'm yet to pay the 3000 pounds deposit
You paid already?

donbreeezy:
I used Skye nd the rate was around 468naira per GBPound

Going for MPH too

cc cyzonsuez

I got the Westminster scholarship too. MPH

Prior to his election as WHO’s next Director-General, Dr Tedros Adhanom Ghebreyesus served as Minister of Foreign Affairs, Ethiopia from 2012-2016 and as Minister of Health, Ethiopia from 2005-2012. He has also served as chair of the Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria; as chair of the Roll Back Malaria (RBM) Partnership Board, and as co-chair of the Board of the Partnership for Maternal, Newborn and Child Health.

As Minister of Health, Ethiopia, Dr Tedros Adhanom Ghebreyesus led a comprehensive reform effort of the country's health system, including the expansion of the country’s health infrastructure, creating 3,500 health centres and 16,000 health posts; expanded the health workforce by 38,000 health extension workers; and initiated financing mechanisms to expand health insurance coverage. As Minister of Foreign Affairs, he led the effort to negotiate the Addis Ababa Action Agenda, in which 193 countries committed to the financing necessary to achieve the Sustainable Development Goals.

As Chair of the Global Fund and of RBM, Dr Tedros Adhanom Ghebreyesus secured record funding for the two organizations and created the Global Malaria Action Plan, which expanded RBM’s reach beyond Africa to Asia and Latin America.

Today the Member States of WHO elected Dr Tedros Adhanom Ghebreyesus as the new Director-General of WHO.

Dr Tedros Adhanom Ghebreyesus was nominated by the Government of Ethiopia, and will begin his five-year term on 1 July 2017.

Prior to his election as WHO’s next Director-General, Dr Tedros Adhanom Ghebreyesus served as Minister of Foreign Affairs, Ethiopia from 2012-2016 and as Minister of Health, Ethiopia from 2005-2012. He has also served as chair of the Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria; as chair of the Roll Back Malaria (RBM) Partnership Board, and as co-chair of the Board of the Partnership for Maternal, Newborn and Child Health.

As Minister of Health, Ethiopia, Dr Tedros Adhanom Ghebreyesus led a comprehensive reform effort of the country's health system, including the expansion of the country’s health infrastructure, creating 3500 health centres and 16 000 health posts; expanded the health workforce by 38 000 health extension workers; and initiated financing mechanisms to expand health insurance coverage. As Minister of Foreign Affairs, he led the effort to negotiate the Addis Ababa Action Agenda, in which 193 countries committed to the financing necessary to achieve the Sustainable Development Goals.

As Chair of the Global Fund and of RBM, Dr Tedros Adhanom Ghebreyesus secured record funding for the two organizations and created the Global Malaria Action Plan, which expanded RBM’s reach beyond Africa to Asia and Latin America.

Dr Tedros Adhanom Ghebreyesus will succeed Dr Margaret Chan, who has been WHO’s Director-General since 1 January 2007.

Source:http://www.who.int/mediacentre/news/releases/2017/director-general-elect/en/

This week, the top health officials from every nation will gather in Geneva for the World Health Assembly, where they will elect a new head of the World Health Organization (WHO). Three candidates are vying for the role of world’s most influential public health leader: Tedros Ghebreyesus, former Minister of Health of Ethiopia; David Nabarro of the UK, an international civil servant and Special Advisor to the UN Secretary General; and Sania Nishtar, former federal minister of the government of Pakistan and founder of a the non-profit Heartfile. All three are highly credentialed global health leaders.

Regardless of who is elected, the new Director-General must lead a deep reform agenda that guides WHO out of its current state marred by entrenched bureaucracy and political partisanship, and into a future where it delivers a high-functioning balance of policy and operations. Without a sea change from within the organization during the coming years, WHO will become less and less relevant. Ultimately, other entities will replace WHO’s role in providing expert guidance to national decision makers. Regional alliances, or global philanthropies hungry to further their mission, or even corporations determined to increase market share all stand at the ready. WHO’s advantage of being the only entity in global health that boasts 194 member states with the ability to mobilize global opinion and shape political will should not be underappreciated. With the right leadership, WHO can ensure a healthier future for all the world’s people.

The key to change at WHO will be a leader that can strategically improve the organization’s overall management. Management theory and practice were barely a science when WHO was created in 1948. In 2010, epidemiologist and former head of the U.S. Centers for Disease Control and Prevention William Foege declared, “lack of management skills appears to be the single biggest barrier to improving health throughout the world.”

The World Health Assembly should take heed. They should select a new WHO Director-General who is not only a principled diplomat, but also a skilled manager capable of implementing the following reforms.

First, WHO should improve its capacity to monitor global health needs in real time, then seek to add value to countries’ own abilities to prevent, detect and respond to disease. WHO cannot be all public health fixes to all countries and people. A value-added system focused on core priorities and WHO’s actual expertise, in response to emerging needs, will set a new standard for the organization and for global public health.

Defining priorities through input from WHO’s leadership and internal experts, governments and other external stakeholders in a way that treats all populations with equal consideration—and then making tough decisions based on the greatest needs—will give WHO greater credibility. It is critical that WHO management designs systems and programs with input from a broader community of social scientists and legal experts, in addition to medical professionals, to help the organization better deliver on its mission in different cultural, political and economic contexts.

Achieving the above will require more flexible funding from WHO donors. Inflexible, unreliable funding is one of WHO’s greatest difficulties. The new Director-General should negotiate for more leeway to distribute member-state dues in the form of technical support and capacity building, as they deem appropriate. They should not allow earmarking by philanthropic partners, a change that would enable faster response to crises.

Lastly, it is imperative that the new Director-General unravels the governance issues that challenge the organization. Rewards and accountability are linked principles in well-managed organizations. WHO should reward positive outcomes while also developing stronger accountability within the organization and its partnerships.

These suggestions are based on the reality that, whatever predictable health challenges we face across the globe in the coming years, there undoubtedly will be new outbreaks and epidemics that require WHO to respond effectively and efficiently. The continued rise of anti-microbial resistance alone practically guarantees this reality.

The outgoing Director-General Margaret Chan has worked hard to bring improvements to the organization. The process for electing the new Director-General is far more transparent than in the past. And when Dr. Chan sought to evaluate what went wrong in WHO’s response to the 2014 Ebola outbreak that lead to the death of nearly 12,000 people—largely in West Africa—an independent expert panel called upon the organization to reform its internal management. Chan has taken steps to advance this reform.

A new Director-General must push the process much further. This is a tall order requiring a skillful manager who can tackle today’s health challenges in their immediacy and complexity. It is the only way to create the WHO that the world needs today.

Source:http://www.realclearhealth.com/articles/2017/05/22/new_leader_of_world_health_organization_must_bring_deep_reform_110602.html

OK




I'm here to steal pictures for my whatsapp status

temmybaba:
Already sent to all ur emails......enjoy

shammakdaprinz@gmail.com

I have another aptitude test scheduled for that day...

Thanks brother

All ladies claiming 8 & 12, who con dey upload pictures 4 facebook

ideologies:
apply first

No problem sire, I will

Nobody is even talking about the IELTS score

That disqualified me

It is well sha

Hope still dey

Meningococcal meningitis is a bacterial form of meningitis, a serious infection of the meninges that affects the brain membrane. It can cause severe brain damage and is fatal in 50% of cases if untreated.

Several different bacteria can cause meningitis. Neisseria meningitidis is the one with the potential to cause large epidemics. There are 12 serogroups of N. meningitidis that have been identified, 6 of which (A, B, C, W, X and Y) can cause epidemics. Geographic distribution and epidemic potential differ according to serogroup.

Transmission

The bacteria are transmitted from person-to-person through droplets of respiratory or throat secretions from carriers. Close and prolonged contact – such as kissing, sneezing or coughing on someone, or living in close quarters (such as a dormitory, sharing eating or drinking utensils) with an infected person (a carrier) – facilitates the spread of the disease. The average incubation period is 4 days, but can range between 2 and 10 days.

Neisseria meningitidis only infects humans; there is no animal reservoir. The bacteria can be carried in the throat and sometimes, for reasons not fully understood, can overwhelm the body's defenses allowing infection to spread through the bloodstream to the brain. It is believed that 10% to 20% of the population carries Neisseria meningitidis in their throat at any given time. However, the carriage rate may be higher in epidemic situations.

Symptoms

The most common symptoms are a stiff neck, high fever, sensitivity to light, confusion, headaches and vomiting. Even when the disease is diagnosed early and adequate treatment is started, 5% to 10% of patients die, typically within 24 to 48 hours after the onset of symptoms. Bacterial meningitis may result in brain damage, hearing loss or a learning disability in 10% to 20% of survivors. A less common but even more severe (often fatal) form of meningococcal disease is meningococcal septicaemia, which is characterized by a haemorrhagic rash and rapid circulatory collapse.

Diagnosis

Initial diagnosis of meningococcal meningitis can be made by clinical examination followed by a lumbar puncture showing a purulent spinal fluid. The bacteria can sometimes be seen in microscopic examinations of the spinal fluid. The diagnosis is supported or confirmed by growing the bacteria from specimens of spinal fluid or blood, by agglutination tests or by polymerase chain reaction (PCR). The identification of the serogroups and susceptibility testing to antibiotics are important to define control measures.

Treatment

Meningococcal disease is potentially fatal and should always be viewed as a medical emergency. Admission to a hospital or health centre is necessary, although isolation of the patient is not necessary. Appropriate antibiotic treatment must be started as soon as possible, ideally after the lumbar puncture has been carried out if such a puncture can be performed immediately. If treatment is started prior to the lumbar puncture it may be difficult to grow the bacteria from the spinal fluid and confirm the diagnosis.

Source:http://www.who.int/mediacentre/factsheets/fs141/en/

What is meningococcal disease?

Meningococcal disease can refer to any illness that is caused by a type of bacteria called Neisseria meningitidis. Meningococcal disease is a contagious infection spread by close contact, such as living with or kissing an infected person. Quick medical attention is extremely important if meningococcal disease is suspected.

The symptoms of meningococcal disease can vary based on the type of illness that develops. Common symptoms of meningococcal meningitis include sudden fever, headache, and stiff neck. Other symptoms can include nausea, vomiting, increased sensitivity to light, and confusion. Children and infants may show different signs, such as inactivity, irritability, vomiting, or poor reflexes. Meningococcal bacteria can also infect the blood which can lead to tiredness, vomiting, cold hands and feet, chills, severe aches and pain, fast breathing, diarrhea, and a dark purple rash. Meningococcal disease is very serious and can be fatal. When fatal, death can occur in as little as a few hours.

Who is at risk?

Anyone can get meningococcal disease, but certain groups of people are at increased risk. Although meningococcal disease is found worldwide, the “meningitis belt” of sub-Saharan Africa has the highest rates in the world. Rates of meningococcal disease are several times higher in the meningitis belt than in the United States. The disease is most common in this part of Africa during the dry season (December through June). Travelers who spend a lot of time with local populations in the meningitis belt, especially during outbreaks of meningococcal disease, have the highest risk of getting the disease.

Participants in the Hajj pilgrimage in Saudi Arabia also are at increased risk.

What can travelers do to prevent meningococcal disease?

Get vaccinated:
Vaccination for meningococcal disease is recommended if you plan to visit a destination in the “meningitis belt” of sub-Saharan Africa during the dry season (December through June), when the disease is more common.

However, there are several types of meningococcal vaccines and not all provide the recommended protection for travelers to these countries. Travelers to this region should get a specific kind of vaccination called quadrivalent meningococcal conjugate vaccine because it protects against strains of the disease found most frequently in this region.

Two vaccines that provide the recommended protection are called Menactra and Menveo.
Even if you have received one of the recommended vaccines before, you may need a booster dose, usually every 5 years if you remain at increased risk.
Infants and young children will need more than one dose of a recommended vaccine.
Those traveling to Saudi Arabia to participate in the Hajj must show proof of quadrivalent meningococcal vaccination. It may also be referred to as tetravalent meningococcal vaccines.
If you're unsure which vaccines you have received or which ones you need before travel, ask your doctor. You can also check CDC's vaccine recommendation page for more details.
It takes 7 to 10 days after receiving the vaccine before a person develops protection against the disease. See your doctor as soon as possible before travel to make sure you are protected.

Reduce your exposure to germs:

Wash your hands often.
If soap and water aren’t available, clean your hands with hand sanitizer (containing at least 60% alcohol).
Don’t touch your eyes, nose, or mouth. If you need to touch your face, make sure your hands are clean.
Cover your mouth and nose with a tissue or your sleeve (not your hands) when coughing or sneezing.
Try to avoid contact with people who are sick.

Source:https://wwwnc.cdc.gov/travel/diseases/meningococcal-disease

Hey fam!
How y'all been

Nowayo4Real:
Hmmmm, I applied for Mechatronic Engineering. Got a mail that am placed in a reserve list and in a self funding list too

Oh.. So what's the plan?